[go: up one dir, main page]

HK1021685B - Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease - Google Patents

Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease Download PDF

Info

Publication number
HK1021685B
HK1021685B HK98114128.9A HK98114128A HK1021685B HK 1021685 B HK1021685 B HK 1021685B HK 98114128 A HK98114128 A HK 98114128A HK 1021685 B HK1021685 B HK 1021685B
Authority
HK
Hong Kong
Prior art keywords
hepatitis
patients
treatment
patient
liver
Prior art date
Application number
HK98114128.9A
Other languages
English (en)
French (fr)
Chinese (zh)
Other versions
HK1021685A1 (en
Inventor
B Chretien Paul
Mutchnick Milton
Original Assignee
Sciclone Pharmaceuticals Inc.
The Board Of Governors Of Wayne State University
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals Inc., The Board Of Governors Of Wayne State University filed Critical Sciclone Pharmaceuticals Inc.
Priority claimed from PCT/US1993/010619 external-priority patent/WO1995012405A1/en
Publication of HK1021685A1 publication Critical patent/HK1021685A1/en
Publication of HK1021685B publication Critical patent/HK1021685B/en

Links

Claims (3)

  1. Verwendung pharmazeutischer Dosiereinheiten, enthaltend eine Hepatitis B-Virus reduzierende Menge an Tα1, zur Herstellung eines Medikaments zur Behandlung von Hepatitis B bei einem Patienten mit Leberzerfall, wobei jede Dosiereinheit 1,6 mg Tα1 umfasst.
  2. Verwendung pharmazeutischer Dosiereinheiten, enthaltend eine Hepatitis B-Virus reduzierende Menge an Tα1, zur Herstellung eines Medikaments zur Behandlung von Hepatitis B bei einem Patienten mit Leberzerfall, wobei jede Dosiereinheit 4 mg Tα1 umfasst.
  3. Verwendung nach Anspruch 1, bei der Tα1 in einem injizierbaren oder infundierbaren zulässigen pharmazeutischen flüssigen Träger vorhanden ist.
HK98114128.9A 1993-11-05 Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease HK1021685B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1993/010619 WO1995012405A1 (en) 1993-11-05 1993-11-05 Method and composition for treatment of patients having decompensated liver disease

Publications (2)

Publication Number Publication Date
HK1021685A1 HK1021685A1 (en) 2000-06-23
HK1021685B true HK1021685B (en) 2004-03-19

Family

ID=

Similar Documents

Publication Publication Date Title
EP1536839B1 (de) Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
US5468729A (en) Method for treatment of autoimmune hepatitis
US5491150A (en) Supplementary therpeutic agents for the treatment of immunodeficiency syndrome
AU2002363248B2 (en) Method of administering a Thymosin alpha 1 peptide
US6362162B1 (en) CML Therapy
EP1023901A1 (de) Heilmittel für hepatitis c und dessen verwendung
EP0731710B1 (de) Thymosin-alpha-1 enthaltende zusammensetzungen zur behandlung von hepatitis b bei patienten mit dekompensierter lebererkrankung
JP2784401B2 (ja) 慢性骨髄性白血病の治療方法
AU685413B2 (en) Method and composition for treatment of patients having decompensated liver disease
HK1021685B (en) Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease
US5750501A (en) Method and composition for treatment of patients having decompensated liver disease
US5317012A (en) Human growth hormone induced improvement in depressed T4/T8 ratio
JP2000506839A (ja) 天然ヒトα―インターフェロンを含む薬剤組成物
JP3869874B2 (ja) 急性肝不全治療剤
NZ258326A (en) The use, in the preparation of a medicament, of thymosin alpha 1 for treatment of patients having decompensated liver disease
AU777456B2 (en) CML therapy
JPH0651639B2 (ja) 後天性免疫不全に関係した骨髄抑止の治療
EP0315300A2 (de) Behandlung von tuberkulösen und nichttuberkulösen mycobakteriellen Infektionen
JP2006232862A (ja) 代償不全肝疾患の患者の治療のための組成物
JPH07188050A (ja) ミニマルｂ型肝炎感染症治療用医薬組成物
PT1535622E (pt) Terapia de melanoma
HK1075418A (en) Chronic myeloid leukemia (cml) therapy
MXPA94008106A (en) Use of alpha1 timosine and a corticoesteroide, and sucposposition for the treatment of hepatitisautoinm
HK1032348B (en) Chronic myeloid leukemia (cml) therapy
WO2001080877A1 (en) Preventives for reinfection after liver transplantation